Quantcast

Latest Cytokine storm Stories

2014-07-17 08:25:12

MONMOUTH JUNCTION, N.J., July 17, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company commercializing its CytoSorb® cytokine adsorber in multiple countries worldwide, announced the PDF availability of the first publication describing the use of CytoSorb® intra-operatively during cardiac surgery at the Ludwig Maximilian University of Munich Hospital - Grosshadern Campus, in Germany....

2014-05-09 19:01:15

Walter and Eliza Hall Institute A protein called SOCS4 has been shown to act as a handbrake on the immune system's runaway reaction to flu infection, providing a possible means of minimizing the impact of flu pandemics. Scientists from Melbourne's Walter and Eliza Hall Institute have found that without SOCS4 the immune response to influenza infection is slowed and there is a vast increase in the number of damaging inflammatory molecules in the lungs. This flood of inflammatory...

2014-05-09 13:32:00

PLOS Certain influenza strains are highly virulent—they cause more serious disease and kill more people. Some of the damage is caused by the stronger immune response such strains elicit, especially in the lung. A study published on May 8th in PLOS Pathogens identifies SOCS4 as a key regulator of the immune response against influenza virus. Lukasz Kedzierski, Sandra Nicholson, and colleagues from the Walter and Eliza Hall Institute of Medical Research and the University of Melbourne,...

2014-05-09 13:29:10

PLOS Highly pathogenic (dangerous) influenza strains elicit a strong immune response which can lead to uncontrolled inflammation in the lung and potentially fatal lung injury. A study published on May 8th in PLOS Pathogens demonstrates the importance of IL-27 for the control of immunopathology—damage to the lung tissue caused by the immune system—and the therapeutic potential of well-timed IL-27 application to treat life-threatening inflammation during lung infection. Alf Hamann,...

2014-03-13 08:27:59

MONMOUTH JUNCTION, N.J., March 13, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses in the intensive care unit, announced that it will sponsor a research symposium entitled: "SIRS and SEPSIS - New Therapy with CytoSorb®" at the 34(th) International Symposium on Intensive Care and Emergency Medicine (ISICEM 2014) in Brussels, Belgium next week. The program is scheduled for...

2014-02-10 23:02:37

A study led by St. Jude Children’s Research Hospital identifies factors that predict flu severity in patients and sets the stage for more effective therapies to prevent flu complications and deaths Memphis, Tenn. (PRWEB) February 10, 2014 St. Jude Children’s Research Hospital scientists have identified a signature immune response that might help doctors identify which newly diagnosed influenza patients are most likely to develop severe symptoms and suffer poor outcomes. The findings...

2012-09-10 11:01:08

Many patients with hypertension are treated with ACE inhibitors. These drugs block the angiotensin converting enzyme (ACE) that regulates the salt and water balance of the body and raises blood pressure. Recent studies by a research team led by Professor Ken Bernstein (Cedars-Sinai Medical Center, Los Angeles, California, USA) have, however, significantly broadened the enzyme´s known task spectrum: The enzyme also plays a key role in blood formation, renal development and male fertility....


Word of the Day
call-note
  • The call or cry of a bird or other animal to its mate or its young.
'Call-note' is newer than 'bird-call,' which originally referred to 'an instrument for imitating the note of birds' but now also refers to 'the song or cry of a bird.'
Related